Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 P911 | DOI: 10.1530/endoabs.110.P911

ECEESPE2025 Poster Presentations Pituitary, Neuroendocrinology and Puberty (162 abstracts)

Evaluation of internalizing symptoms in mothers of girls diagnosed with central precocious puberty: a pre- and post-treatment analysis

Dilek Bingöl Aydın 1 , Şeyma Taş 2 , Zehra Koyuncu 3 , Burak Doğangün 3 & Oya Ercan 4


1Tatvan State Hospital, Pediatric Endocrinology, Bitlis, Türkiye; 2Istanbul University-Cerrahpaşa, Department of Pediatrics, Istanbul, Türkiye; 3Istanbul University-Cerrahpaşa, Child and Adolescent Pschitry, Istanbul, Türkiye; 4Private Memorial Şişli Hospital, Pediatric Endocrinology, Istanbul, Türkiye


JOINT3685

Objective: Precocious puberty can be a significant source of stress not only for affected children but also for their families, particularly their mothers. This study aims to assess the presence of internalizing symptoms—stress, anxiety, and depression—in mothers of girls diagnosed with central precocious puberty (CPP) and to evaluate how these symptoms change following treatment.

Methods: This prospective study included mothers of girls diagnosed with CPP who presented to our pediatric endocrinology clinic. The Depression, Anxiety, and Stress Scale-21 (DASS-21) was administered before and after treatment. Mothers with a history of psychiatric illness, those using psychotropic medications, or those whose children were not diagnosed with CPP were excluded. Data from 38 participants were analyzed using the Jamovi 2.2.5 statistical software.

Results: The mean age of the girls at diagnosis was 7.01 ± 0.96 years. The mean age of the mothers was 40.1 ± 5.95 years, while the fathers’ mean age was 43 ± 6.18 years. The median time from initial presentation to diagnosis was 2.5 months (IQR: 1), and the mean duration from treatment initiation to reassessment was 12 ± 8.05 months. At baseline, the median maternal stress score was 4 (IQR: 5), anxiety score was 4 (IQR: 3.75), depression score was 3 (IQR: 4), and total DASS score was 11 (IQR: 10.3). Clinically significant stress, anxiety, and depression were observed in 21.1%, 52.6%, and 31.6% of mothers, respectively. Following an average of 12 months of treatment, the median stress score decreased to 2 (IQR: 5), anxiety score to 1.5 (IQR: 4), depression score to 0 (IQR: 2.75), and total DASS score to 4 (IQR: 10.5). The prevalence of clinically significant stress, anxiety, and depression dropped to 2.6%, 28.9%, and 15.8%, respectively. Statistical analysis confirmed a significant reduction in all internalizing symptoms post-treatment (P < 0.01). No significant correlations were found between DASS scores and child’s age, time to diagnosis, maternal age, or paternal age.

Conclusion: These findings suggest that mothers of children with CPP experience significant psychological distress at the time of diagnosis, which improves following treatment. Given the emotional burden associated with early puberty, incorporating psychosocial support into the management of CPP could be beneficial for both patients and their families.

Keywords: anxiety, depression, puberty precocious, psychiatry, stress.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches